Mr. Baron brings to Janus an extensive experience in the pharmaceutical industry as a Partner at Extera Partners; SVP of Corporate Development at BioAssets; a member of the M&A Team at Millennium Pharmaceuticals; and Consultant for Booz Allen.
Dr. Lipford has over 25 years of research experience in field of immunology at Selecta, Pfizer, Coley Pharmaceuticals, and TUM, 15 of which have been in the area of Toll-Like Receptors (TLRs). He is an author on over 100 publications and named as an inventor on over 30 primary patents.
Dr. Zepp has more than 25 years of medicinal chemistry experience at Selecta, Pfizer, Coley Pharmaceuticals, and Sepracor and is an inventor on over 50 patents. He brings to the company unique expertise in the design, synthesis, and optimization of small molecule antagonists for TLRs 7, 8, and 9.